TAK-168
/ Takeda, Kumquat Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 12, 2025
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
(clinicaltrials.gov)
- P1 | N=84 | Recruiting | Sponsor: Kumquat Biosciences Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1